Blank BioYC S25 landing page report.
← Back to YC S25

Your landing page’s weakest score is Trust.

Fix Trust

Score over time

807060504030Caris Life Sciences 52 on May 4 (Wayback)Caris Life Sciences 52 on May 17 (Wayback)Caris Life Sciences 51 on Jun 10 (Wayback)Caris Life Sciences 52 on Jun 17 (Wayback)Caris Life Sciences 57 on Jul 15 (Wayback)Caris Life Sciences 57 on Sep 8 (Wayback)Caris Life Sciences 56 on Sep 22 (Live)Ocean Genomics 65 on Sep 22 (Live)SOPHiA GENETICS 42 on Jun 16 (Wayback)SOPHiA GENETICS 60 on Jun 24 (Wayback)SOPHiA GENETICS 58 on Jul 16 (Wayback)SOPHiA GENETICS 42 on Jul 26 (Wayback)SOPHiA GENETICS 58 on Aug 11 (Wayback)SOPHiA GENETICS 58 on Sep 8 (Wayback)SOPHiA GENETICS 58 on Sep 22 (Live)BostonGene 54 on Apr 8 (Wayback)BostonGene 56 on May 5 (Wayback)BostonGene 65 on Sep 22 (Live)Blank Bio 68 on Apr 19 (Wayback)Blank Bio 61 on May 19 (Wayback)Blank Bio 61 on Jun 17 (Wayback)Blank Bio 64 on Sep 14 (Wayback)Blank Bio 62 on Sep 22 (Live)Apr 19May 19Jun 17Sep 14Sep 22
Past reportsShow past reportsHide past reports
  1. Sep 22, 202662LiveOverall −2 · Mobile web −6 · Information hierarchy +4Viewing
  2. Sep 14, 202664Overall +3 · Mobile web +10 · CTA +8View →
  3. Jun 17, 202661CTA −4 · Trust +4View →
  4. May 19, 202661Overall −7 · Mobile web −24 · Information hierarchy −8View →
  5. Apr 19, 202668First tracked report — strongest Mobile web 82, weakest Trust 48View →

Trust

48Poor

Proof that the product is real, competent, and safe to try.

Blank Bio
BostonGene
Caris Life Sciences
Trust read
Blank BioNews banner: "Blank Bio announces seed financing and strategic collaboration with PacBio"
Caris Life SciencesBanner: "Caris Detect™ Multi-Cancer Early Detection Test Now Available."
Ocean GenomicsNo visible trust signal identified.
SOPHiA GENETICS"Investors" nav link signaling a publicly traded company
BostonGeneTestimonial from Jorge Reis-Filho, MD, PhD, Chief of AI for Science Innovation, Enterprise AI Unit, AstraZeneca, alongsi

CTA

62Fair

Copy, size, verb, cost-feel — does the primary CTA earn the click?

Blank Bio
Ocean Genomics
BostonGene

Problems

  • styled as text link, not button
  • 'Request' feels like asking permission
  • weaker visually than nav 'Contact'
  • no payoff implied by label

Mobile web

62Fair

The phone experience as a first-class citizen.

Mobile web annotations on the mobile capture123
  1. Request early access link — Primary CTA is a thin text link, not a thumb-sized full-width button.
  2. News announcement banner — Three stacked lines plus a Read more link eat the top of the fold and route the first tap to a press release.
  3. Read more link — Styled identically to the primary CTA below, splitting attention between two underlined arrow links.

Value props

68Fair

Title, subtitle, hero — do they sell the product's true value?

Blank Bio’s headline undersellsRNA intelligence for precision oncologyBlank Bio enables pharma teams to identify the right patients for their clinical trials and predict how their disease will progress.

Working

  • Subhead names buyer: pharma teams
  • Two concrete jobs named in subhead
  • PacBio news bar adds credibility

Could improve

  • H1 is category label, not outcome
  • No numbers or proof in the fold
  • No visual showing the product working

Information hierarchy

72Fair

Does the design help or inhibit what the page is trying to say?

Information hierarchy annotations on the desktop capture1234
  1. Request early access link — Primary CTA is a thin underlined text link, visually weaker than the outlined Contact button above it.
  2. Contact button — The only element styled like a button in the fold, outranking the primary conversion action.
  3. News banner Read more — Top-of-page link styled identically to the primary CTA, pulling first attention off the page.
  4. About Us paragraphs — Dense two-paragraph text wall enters the fold and dilutes the single-message hero.